NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-OH-21-005 from the NIH Guide for Grants and Contracts
Notice NOT-OH-21-004 from the NIH Guide for Grants and Contracts
Notice NOT-OD-21-008 from the NIH Guide for Grants and Contracts
Notice NOT-OD-21-007 from the NIH Guide for Grants and Contracts
Notice NOT-MD-21-003 from the NIH Guide for Grants and Contracts
Notice NOT-NS-21-012 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DK-20-020 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on: Research Experiences Courses for Skills Development This FOA solicits applications to establish research programs for qualified graduate students, post-doctoral trainees, medial residents, engineers, and clinical fellows to engage in neuroscience research experiences relevant to the mission of NIDDK and its partnership with the Common Fund program, Stimulating Peripheral Activity to Relieve Conditions (SPARC). The intent is to leverage this partnership to provide resources for short-term research training experiences that would necessarily use SPARC-generated resources (datasets/maps/models) as the foundation for the research experience in conjunction with didactic training that may be combined with hands-on computational or wet lab projects. The goal is that the research experiences will be impactful and ideally develop new skills and produce new knowledge that could sustain future NIDDK-funded research careers
Notice NOT-NS-20-107 from the NIH Guide for Grants and Contracts
Notice NOT-DE-20-035 from the NIH Guide for Grants and Contracts
Notice NOT-OD-21-005 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-CA-20-054 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites applications to develop and apply innovative synthetic biology approaches to address challenges across the spectrum of cancer research. Projects will be required to apply a technology, based on an engineered biological system, to an important and well-defined cancer research question. Collaborative transdisciplinary teams are expected with PIs representing expertise in cancer research, engineering, and other disciplines relevant to synthetic biology.
Notice NOT-MD-21-004 from the NIH Guide for Grants and Contracts
Notice NOT-MH-21-060 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-MH-21-165 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports research to understand causal linkages across different scales (e.g., molecular, cellular, circuit, behavioral, clinical) relevant to neuropsychiatric disorders. The Convergent Neuroscience (CN) program goal is to establish theoretical models to show how specific constituent processes at one level of analysis contribute to quantifiable properties at other levels, either directly or as emergent phenomenon. Studies should incorporate four key features: (1) a premise on identifying the causal and disease-relevant relationships between objective genetic/biological/clinical criteria at two or more contiguous levels of analysis, whether involving human subjects or experimentally tractable in vivo or in vitro paradigms (genetic variation can be one of the contiguous levels of analysis or can be the context in which other, higher levels of analysis are linked); (2) use of the large and diverse datasets existing or generated at these levels of analysis to develop testable theoretical models within three years of award; (3) experimental testing of the model-based predictions to confirm or reject their validity, (4) preferential utilization of scalable approaches to maximize analytic throughput, content, sensitivity, selectivity, spatiotemporal resolution and robustness. Results should yield causal linkages between levels of analysis and mechanistically explain key functional dimension(s) relevant to mental illness pathophysiology. Leadership of research teams will include expertise in experimental neurobiology or clinical research paired with orthogonal theoretical disciplines (e.g., mathematics, computation, physics). This endeavor will be facilitated by active participation in a community-driven manner through the CN Consortium. Groups will manage their data and analysis methods using a harmonized framework with other U19 awardees through a CN Consortium Data Commons structure.
Funding Opportunity PAR-21-032 from the NIH Guide for Grants and Contracts. (Reissue of PAR-20-021) The purpose of this award is to support outstanding scientific training of highly promising postdoctoral candidates with outstanding mentors. Candidates are eligible to apply for support from this program from ~12 months prior to the start of the proposed postdoctoral position to within 12 months after starting in postdoctoral position. Based on the early timeframe of eligibility, and the discouragement of inclusion of preliminary data, this NINDS F32 seeks to foster early, goal-directed planning and to encourage applications for bold and/or innovative projects by the candidate that have the potential for significant impact. Applications are expected to incorporate strong training in quantitative reasoning and the quantitative principles of experimental design and analysis. Support by this program is limited to the first 3 years of a candidate's activity in a specific laboratory or research environment, so as to further encourage early fellowship application and timely completion of mentored training of the postdoctoral candidate in a single environment.
Notice NOT-MH-21-005 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-AA-20-013 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism intends to renew an initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications for collaborative research projects (U01) to investigate brain mechanisms of excessive alcohol drinking and related phenotypes associated with alcohol use disorder (AUD). The U01s are components of a Consortium on the Integrative Neuroscience Initiative on Alcoholism (INIA).
Funding Opportunity RFA-AA-20-012 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits research cooperative agreements to participate in two consortia under the Integrative Neuroscience Initiative on Alcoholism (INIA). This FOA solicits submission of Research Resource core applications (U24) to support the consortium. Please see companion RFA-AA-20-011 for submission an Administrative Resource core application, and companion RFA-AA-20-013 for submission of Research Project applications (U01).
Funding Opportunity RFA-AA-20-011 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits cooperative agreements to participate in two consortia under the Integrative Neuroscience Initiative on Alcoholism (INIA). This FOA solicits submission of administrative resource cores (U24) applications. Please see companion FOAs for submission of resource-related and support cores (U24) applications, RFA-AA-20-012, and for submission of collaborative research projects (U01) applications, RFA-AA-20-013 .
Funding Opportunity PAR-21-028 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) intends to support investigators who have interest and capability to join efforts for the discovery of cell-based chemical probes for novel brain targets. It is expected that applicants will have in hand the starting compounds (validated hits) for chemical optimization and bioassays for testing new analog compounds. Through this FOA, NIH wishes to stimulate research in: 1) discovery and development of novel, small molecules for their potential use in understanding biological processes relevant to the missions of NIMH, NIA, NICHD, and/or NIDCD; and 2) discovery and/or validation of novel, biological targets that will inform studies of brain disease mechanisms. Emphasis will be placed on projects that provide new insight into important disease-related biological targets and biological processes. The main emphasis of projects submitted under this FOA should be in the discovery of cell-based chemical probes. Applicants interested in developingin vivochemical probes may wish to apply using the companion R01 mechanism TEMP-8444.